| ISIN | CH0023406587 |
|---|---|
| Valor Number | 2340658 |
| Bloomberg Global ID | MICHSWA SW |
| Fund Name | Migros Bank (CH) Fonds - SwissStock A |
| Fund Provider |
Migros Bank AG, Zurich
Web: www.migrosbank.ch/kontakt |
| Fund Provider | Migros Bank AG, Zurich |
| Representative in Switzerland | |
| Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
| Asset Class | Equities |
| EFC Category | Equity Switzerland |
| Distribution Policy | Distribution |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The investment objective of Mi-Fonds (CH) - Swiss Stock is principally to achieve long-term performance, which is consistent with the development of the Swiss equity market. |
| Peculiarities |
| Current Price * | 186.79 CHF | 07.01.2026 |
|---|---|---|
| Previous Price * | 186.50 CHF | 06.01.2026 |
| 52 Week High * | 186.79 CHF | 07.01.2026 |
| 52 Week Low * | 149.82 CHF | 09.04.2025 |
| NAV * | 186.79 CHF | 07.01.2026 |
| Issue Price * | 186.79 CHF | 07.01.2026 |
| Redemption Price * | 186.79 CHF | 07.01.2026 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 559,290,800 | |
| Unit/Share Assets *** | 106,114,548 | |
| Trading Information SIX | ||
| YTD Performance | +0.95% |
31.12.2025 - 07.01.2026
31.12.2025 07.01.2026 |
|---|---|---|
| 1 month | +3.04% |
08.12.2025 - 07.01.2026
08.12.2025 07.01.2026 |
| 3 months | +6.14% |
07.10.2025 - 07.01.2026
07.10.2025 07.01.2026 |
| 6 months | +9.86% |
07.07.2025 - 07.01.2026
07.07.2025 07.01.2026 |
| 1 year | +15.03% |
07.01.2025 - 07.01.2026
07.01.2025 07.01.2026 |
| 2 years | +23.36% |
08.01.2024 - 07.01.2026
08.01.2024 07.01.2026 |
| 3 years | +25.07% |
09.01.2023 - 07.01.2026
09.01.2023 07.01.2026 |
| 5 years | +32.66% |
07.01.2021 - 07.01.2026
07.01.2021 07.01.2026 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 13.03% | |
|---|---|---|
| Nestle SA | 11.39% | |
| Novartis AG Registered Shares | 10.96% | |
| UBS Group AG Registered Shares | 5.91% | |
| Compagnie Financiere Richemont SA Class A | 5.63% | |
| Zurich Insurance Group AG | 5.23% | |
| ABB Ltd | 5.05% | |
| Lonza Group Ltd | 2.64% | |
| Swiss Re AG | 2.36% | |
| Alcon Inc | 2.09% | |
| Last data update | 30.11.2025 | |
| TER | 0.90% |
|---|---|
| TER date | 30.06.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.90% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |